In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C lands $83mm for uBiome

Executive Summary

Microbial genomics firm uBiome Inc. raised $83mm in its Series C financing led by OS Fund, which was joined by investors including 8VC, Y Combinator, and Dentsu Ventures. The six-year-old firm will use the proceeds for portfolio development, to expand into drug R&D using existing patent assets and research collaborations rather than data sales, to continue commercializing its SmartGut, SmartJane, Explorer diagnostics, and to commence commercialization of biopharma molecules and live biotherapeutics. UBiome concurrently announced that former Novartis CEO Joseph Jimenez will join the board.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies